Please use this identifier to cite or link to this item:
|Title:||Detection of delta-9-tetrahydrocannabinol (THC) in oral fluid, blood and urine following oral consumption of low-content THC hemp oil.|
|Authors:||Hayley, Amie C;Downey, Luke A;Hansen, Glyn;Dowell, Ashley;Savins, Dale;Buchta, Richard;Catubig, Reinilda;Houlden, Robert;Stough, Con K K|
|Affiliation:||Centre for Human Psychopharmacology, Swinburne University of Technology, Hawthorn, Australia|
Institute for Breathing and Sleep, Austin Health, Heidelberg, Victoria, Australia
Drugs and Driving Toxicology, NSW Forensic & Analytical Science Service, Lidcombe, NSW, Australia
Analytical Research Laboratory (ARL), Southern Cross Plant Science (SCPS), Southern Cross University (SCU), Lismore, NSW, Australia
Formulytica Pty.Ltd., Mulgrave, Australia
|Citation:||Forensic science international 2018; 284: 101-106|
|Abstract:||Hemp-derivative (Cannabis sativa L.) food products containing trace levels of Δ-9-tetrahydrocannabinol (THC) are proposed for consumption in Australia and New Zealand; however, it is unclear whether use of these products will negatively affect existing drug screening protocols. This double-blind, within-subjects, cross-over trial assessed 35 adults (17 male; 18 female), aged 22-52 years [Mean=30.7, Standard Deviation (S.D)±7.6]. Low dose THC oil [5mL bearer sesame oil containing 10mg/kg THC (0.046mg THC per 5mL dose)]; high dose THC oil [5mL bearer sesame oil containing 20mg/kg THC (0.092mg THC per 5mL dose)]; and a placebo oil (THC negative) was consumed during a three-week protocol. The Securetec Drugwipe® II Twin device assessed THC presence (cut-off 20ng/mL) in oral fluid at baseline, at 5, 30, 60, 120 and 240min post-treatment. Blood was drawn at baseline, 30, 120 and 240min post-treatment, and urine at baseline and 240min post-treatment. No THC was detected in oral fluid, blood or urine samples at any time-point following consumption of the low or high THC dose. Trace concentrations of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid (THCa) were detected in blood 4-h after consumption of the high THC treatment (M=0.0001mg/L) and in urine at 4-h post consumption of both low and high THC treatments (M=0.0001mg/L and 0.0004mg/L, respectively). Consumption of low-content THC oil does not result in positive biological assessments. It is therefore highly unlikely that ingestion of products containing these levels of THC will negatively impact existing region-specific drug driving enforcement protocols.|
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.